CRBP Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/27/2014
Outstanding shares:  125,230,881
Average volume:  1,294,685
Market cap:   $110,704,099
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    21833P103
ISIN:        US21833P1030
Valuation   (See tab for details)
PE ratio:   -2.42
PB ratio:   1.37
PS ratio:   71.89
Return on equity:   -56.67%
Net income %:   -2,856.77%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy